Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Affimed (DE:A28)
STUTTGART:A28
Affimed (A28) Stock Price & Analysis
0 Followers
A28 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€2.91 - €10.19
Previous Close€4.87
Volume1.00K
Average Volume (3M)1.28K
Market Cap
€73.55M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Beta1.40
Next Earnings
Mar 20, 2024EPS Estimate
-€1.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,282
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.57Price Target Upside-1.98% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Affimed News
PremiumPress Releases
Affimed Announces 1-for-10 Reverse Stock Split
A28 FAQ
What was Affimed’s price range in the past 12 months?
Affimed lowest stock price was €2.91 and its highest was €10.19 in the past 12 months.
What is Affimed’s market cap?
Currently, no data Available
When is Affimed’s upcoming earnings report date?
Affimed’s upcoming earnings report date is Mar 20, 2024 which is 46 days ago.
How were Affimed’s earnings last quarter?
Affimed released its earnings results on Nov 14, 2023. The company reported -€1.6 earnings per share for the quarter, beating the consensus estimate of -€1.842 by €0.242.
Is Affimed overvalued?
According to Wall Street analysts Affimed’s price is currently Overvalued.
Does Affimed pay dividends?
Affimed does not currently pay dividends.
What is Affimed’s EPS estimate?
Affimed’s EPS estimate is -€1.54.
How many shares outstanding does Affimed have?
Currently, no data Available
What happened to Affimed’s price movement after its last earnings report?
Affimed reported an EPS of -€1.6 in its last earnings report, beating expectations of -€1.842. Following the earnings report the stock price went down -3.515%.
Which hedge fund is a major shareholder of Affimed?
Among the largest hedge funds holding Affimed’s share is Baker Bros Advisors LP. It holds Affimed’s shares valued at N/A.
---
Affimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€4.57 (-1.98% Downside)
€4.57 (-1.98% Downside)
Blogger Sentiment
Bullish
DE:A28 Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.80%
12-Months-Change
Fundamentals
Return on Equity
-98.26%
Trailing 12-Months
Asset Growth
-44.93%
Trailing 12-Months
Company Description
Affimed
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
---
A28 Earnings Call
Q3 2023
0:00 / 0:00
---
A28 Stock 12 Months Forecast
Average Price Target
€4.57
▼(-1.98% Downside)
Technical Analysis
Best Analysts Covering A28
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-14.69%
reiterated a buy rating 5 months ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -14.69% per trade.
---